ruben mesa, md: myelofibrosis patients frequently present symptoms
Published 5 years ago • 1.3K plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:55
ruben mesa, md: ruxolitinib as a myelofibrosis treatment
-
30:30
dr ruben mesa-myelofibrosis and advancing mpns: current and future approaches
-
17:41
for myelofibrosis patients: the latest on promising treatments from top specialist | dr. ruben mesa
-
1:10
dr. ruben mesa on comfort-1 for myelofibrosis
-
0:33
ruben mesa, md discusses pathophysiology and treatment of myelofibrosis
-
1:52
ruben mesa, md on myelofibrosis (full interview)
-
1:49
dr ruben mesa on fedratinib’s impact on health-related quality of life
-
1:37
dr ruben mesa outlines the quality of life impact of myelofibrosis
-
59:09
professor ruben mesa: living with an mpn
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
26:22
key takeaways in mpns
-
1:31
dr ruben mesa discusses better understanding symptoms in mpns
-
0:57
dr. mesa on challenges in myelofibrosis treatment
-
0:44
ruben mesa, md discusses supportive care for myelofibrosis patients
-
3:13
ash impact series: ruben mesa, md - examining the current role of ruxolitinib in myelofibrosis
-
51:55
ruben mesa, md, ut health san antonio
-
5:12
dr. ruben mesa discusses asco 2023 updates from the simplify trials in myelofibrosis
-
1:00
dr. mesa on the utility of ruxolitinib versus fedratinib in myelofibrosis
-
1:11
dr. mesa on the utility of fedratinib for patients with myelofibrosis who progress on ruxolitinib
-
5:33
ruben mesa, md: momelotinib non-inferior to ruxolitinib in myelofibrosis
-
0:55
dr. mesa on intended patients with myelofibrosis for pacritnib
-
1:33
dr. mesa on late-stage trials in myelofibrosis